{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:29:19Z","timestamp":1792582159566,"version":"4.5.0"},"reference-count":20,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The aim of the study was to longitudinally assess swallowing abilities in nusinersen-treated patients with type 1 spinal muscular atrophy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty infants with type 1 SMA (11 female and 9 male) treated with nusinersen between 3 weeks and 15 months of age, were assessed using the Oral and Swallowing Abilities Tool (OrSAT). The duration of the follow-up after treatment ranged between 12 months and 62 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twelve of the 20 infants had normal swallowing and there was no need for tube feeding at the time treatment started. Ten of the 12 had consistently normal swallowing with no need for tube feeding on follow-up. The other two required tube feeding but they regained the ability to eat some food by mouth.<\/jats:p><jats:p>The remaining 8 infants already had tube feeding inserted at the time treatment started: 4 of them also had tracheostomy and they showed no changes on the OrSAT Scale. The other 4 who had tube feeding but no tracheostomy had partial functional improvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that the degree of functional impairment at the time treatment is started can help to predict the progression of swallowing abilities. The use of a structured assessment also helped to detect partial improvements.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2022-323899","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T17:36:09Z","timestamp":1653327369000},"page":"912-916","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patients"],"prefix":"10.1136","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5698-9415","authenticated-orcid":false,"given":"Beatrice","family":"Berti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Stanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3128-6657","authenticated-orcid":false,"given":"Roberta","family":"Onesimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"de Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Carnicella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Norcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Forcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Coratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ausili Cefaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-5365","authenticated-orcid":false,"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"2023093005401568000_107.10.912.1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-71"},{"key":"2023093005401568000_107.10.912.2"},{"key":"2023093005401568000_107.10.912.3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/dmcn.14412","article-title":"Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen","volume":"62","author":"Aragon-Gawinska","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"2023093005401568000_107.10.912.4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01414-8"},{"key":"2023093005401568000_107.10.912.5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.25533","article-title":"Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data","volume":"86","author":"Pane","year":"2019","journal-title":"Ann Neurol"},{"key":"2023093005401568000_107.10.912.6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/JND-190441","article-title":"Treatment with Nusinersen - Challenges Regarding the Indication for Children with SMA Type 1","volume":"7","author":"Pechmann","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"2023093005401568000_107.10.912.7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpeds.2019.12.047","article-title":"Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen","volume":"219","author":"Sansone","year":"2020","journal-title":"J Pediatr"},{"key":"2023093005401568000_107.10.912.8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/JND-200614","article-title":"Oral and swallowing abilities tool (OrSAT) for type 1 SMA patients: development of a new module","volume":"8","author":"Berti","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"2023093005401568000_107.10.912.9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2017.09.015","article-title":"Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy","volume":"28","author":"De Sanctis","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2023093005401568000_107.10.912.10","doi-asserted-by":"publisher","DOI":"10.1016\/0960-8966(94)00075-K"},{"key":"2023093005401568000_107.10.912.11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2023093005401568000_107.10.912.12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JND-190379","article-title":"Bulbar problems self-reported by children and adults with spinal muscular atrophy","volume":"6","author":"van der Heul","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"2023093005401568000_107.10.912.13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1044\/2021_AJSLP-20-00217","article-title":"Dysphagia phenotypes in spinal muscular atrophy: the past, present, and promise for the future","volume":"30","author":"McGrattan","year":"2021","journal-title":"Am J Speech Lang Pathol"},{"key":"2023093005401568000_107.10.912.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706198"},{"key":"2023093005401568000_107.10.912.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710504"},{"key":"2023093005401568000_107.10.912.16","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2102047"},{"key":"2023093005401568000_107.10.912.17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S1474-4422(21)00251-9","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial","volume":"20","author":"Mercuri","year":"2021","journal-title":"Lancet Neurol"},{"key":"2023093005401568000_107.10.912.18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial","volume":"20","author":"Day","year":"2021","journal-title":"Lancet Neurol"},{"key":"2023093005401568000_107.10.912.19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JND-200593","article-title":"Safety monitoring of gene therapy for spinal muscular atrophy with Onasemnogene Abeparvovec -A single centre experience","volume":"8","author":"Friese","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"2023093005401568000_107.10.912.20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000741"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2022-323899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T12:44:00Z","timestamp":1696077840000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2022-323899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,9,20]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/archdischild-2022-323899"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2022-323899","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]}}}